col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Ovid: Neurology Neuroimmunology & Neuroinflammation
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―14 Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19 Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, Christopher Nelke, Anke Lux, Refik Pul, et al. (+15)
2 [GO] 2021―Jul―02 COVID-19 Among Patients With Multiple Sclerosis
3 [GO] 2021―Jun―24 SARS-CoV-2 Infection in Multiple Sclerosis Georgina Arrambide, Miguel Ángel Llaneza-González, Lucienne Costa-Frossard França, Virginia Meca-Lallana, Eva Fernández- Díaz, Irene Moreno-Torres, et al. (+34)
4 [GO] 2021―Jun―16 Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation Raphael Bernard-Valnet, Sylvain Perriot, Mathieu Canales, Beatrice Pizzarotti, Leonardo Caranzano, Mayté Castro-Jiménez, et al. (+11)
5 [GO] 2021―May―21 Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2
6 [GO] 2021―May―20 COVID-19 Among Patients With Multiple Sclerosis Mahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh, Alireza Afshari-Safavi, Nasim Nehzat, Saeed Vaheb, et al. (+2)
7 [GO] 2021―Apr―14 Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2 Mario Sa, Luwaiza Mirza, Michael Carter, Lalani Carlton Jones, Vasantha Gowda, Jennifer Handforth, et al. (+15)
8 [GO] 2021―Jan―27 Presence of SARS-CoV-2 Transcripts in the Choroid Plexus of MS and Non-MS Patients With COVID-19 Vidmante Fuchs, Michael Kutza, Sven Wischnewski, Nikolaus Deigendesch, Luc Lutz, Laila Kulsvehagen, et al. (+7)
9 [GO] 2021―Jan―27 Incidence and Impact of COVID-19 in MS Maria Sepúlveda, Sara Llufriu, Eugenia Martínez-Hernández, Martí Català, Montse Artola, Ana Hernando, et al. (+12)
10 [GO] 2020―Dec―16 Acute disseminated encephalomyelitis after SARS-CoV-2 infection
11 [GO] 2020―Dec―11 Presentations and mechanisms of CNS disorders related to COVID-19 Marta Bodro, Yaroslau Compta, Raquel Sánchez-Valle
12 [GO] 2020―Aug―21 N2 in the time of COVID-19 Josep Dalmau
13 [GO] 2020―Aug―13 Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency Steffen Pfeuffer, Matthias Pawlowski, Gunther S. Joos, Jens Minnerup, Sven G. Meuth, Rainer Dziewas, Heinz Wiendl
14 [GO] 2020―Jul―10 COVID-19 outcomes in MS Erica Parrotta, Ilya Kister, Leigh Charvet, Carrie Sammarco, Valerie Saha, Robert Erik Charlson, et al. (+9)
15 [GO] 2020―Jul―10 Guillain-Barré syndrome related to SARS-CoV-2 infection
16 [GO] 2020―Jul―02 Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2-associated encephalitis Marta Bodro, Yaroslau Compta, Laura Llansó, Diana Esteller, Antonio Doncel-Moriano, Alex Mesa, et al. (+11)
17 [GO] 2020―Jun―26 Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond? Adil Maarouf, Audrey Rico, Clemence Boutiere, Marine Perriguey, Sarah Demortiere, Jean Pelletier, Bertrand Audoin
18 [GO] 2020―Jun―26 COVID-19-associated ophthalmoparesis and hypothalamic involvement Elba Pascual-Goñi, Juan Fortea, Alejandro Martínez-Domeño, Nuria Rabella, Mario Tecame, Cristina Gómez-Oliva, et al. (+2)
19 [GO] 2020―Jun―12 Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019? Cole Maguire, Teresa Frohman, Scott S. Zamvil, Elliot Frohman, Esther Melamed
20 [GO] 2020―Jun―11 CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19 Ashwin A. Pinto, Liam S. Carroll, Vijay Nar, Aravinthan Varatharaj, Ian Galea
21 [GO] 2020―Jun―11 COVID-19-associated acute necrotizing myelitis Javier Sotoca, Yensa Rodríguez-Álvarez
22 [GO] 2020―Jun―10 Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease Marinos C. Dalakas
23 [GO] 2020―Jun―05 Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19 Ahmed Elkady, Alejandro A. Rabinstein
24 [GO] 2020―Jun―05 Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders Moli Fan, Wei Qiu, Bitao Bu, Yan Xu, Huan Yang, Dehui Huang, et al. (+10)
25 [GO] 2020―Jun―02 Acute disseminated encephalomyelitis after SARS-CoV-2 infection Giovanni Novi, Tommaso Rossi, Enrico Pedemonte, Laura Saitta, Claudia Rolla, Luca Roccatagliata, et al. (+2)
26 [GO] 2020―May―28 Guillain-Barré syndrome related to SARS-CoV-2 infection Kévin Bigaut, Martial Mallaret, Seyyid Baloglu, Benjamin Nemoz, Patrice Morand, Florent Baicry, et al. (+5)
27 [GO] 2020―May―23 COVID-19-White matter and globus pallidum lesions Gilles Brun, Jean-François Hak, Stéphanie Coze, Elsa Kaphan, Julien Carvelli, Nadine Girard, Jan-Patrick Stellmann
28 [GO] 2020―May―16 COVID-19 and MS disease-modifying therapies Joseph R. Berger, Rachel Brandstadter, Amit Bar-Or
29 [GO] 2020―May―06 COVID-19 infection in a patient with multiple sclerosis treated with fingolimod Mahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, Reza Sarrafi, Farzin Khorvash, Amir-Hadi Maghzi, Vahid Shaygannejad
30 [GO] 2020―Apr―30 Guillain-Barré syndrome related to COVID-19 infection Paola Alberti, Simone Beretta, Marco Piatti, Aristotelis Karantzoulis, Maria Luisa Piatti, Patrizia Santoro, et al. (+6)


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.004 sec